From animal models to gut-on-chip: the challenging journey to capture inter-individual variability in chronic digestive disorders

References

• World Health Organization (WHO). Global health estimates 2019: estimated deaths by age, sex, and cause.
   Google Scholar
• Jeon YH, Essue B, Jan S, Wells R, Whitworth JA. Economic hardship associated with managing chronic illness: a qualitative inquiry. BMC Health Serv Res. 2009;9(1):182–10. doi:10.1186/1472-6963-9-182.
   PubMed Web of Science ®Google Scholar
• Jairath V, Feagan BG. Global burden of inflammatory bowel disease. Lancet Gastroenterol Hepatol. 2020;5(1):2–3. doi:10.1016/S2468-1253(19)30358-9.
   PubMed Web of Science ®Google Scholar
• Oka P, Parr H, Barberio B, Black CJ, Savarino EV, Ford AC. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5(10):908–917. doi:10.1016/S2468-1253(20)30217-X.
   PubMed Web of Science ®Google Scholar
• Marsal J, Barreiro-de Acosta M, Blumenstein I, Cappello M, Bazin T, Sebastian S. Management of non-response and loss of response to anti-tumor necrosis factor therapy in inflammatory bowel disease. Front Med. 2022;9:897936. doi:10.3389/fmed.2022.897936.
   Web of Science ®Google Scholar
• Rodriguez JM, Monsalves-Alvarez M, Henriquez S, Llanos MN, Troncoso R. Glucocorticoid resistance in chronic diseases. Steroids. 2016;115:182–192. doi:10.1016/j.steroids.2016.09.010.
   PubMed Web of Science ®Google Scholar
• Li H, He J, Jia W. The influence of gut microbiota on drug metabolism and toxicity. Expert Opin Drug Metab Toxicol. 2016;12:31–40. doi:10.1517/17425255.2016.1121234.
   PubMed Web of Science ®Google Scholar
• Zhao Q, Chen Y, Huang W, Zhou H, Zhang W. Drug-microbiota interactions: an emerging priority for precision medicine. Signal Transduct Target Ther. 2023;8:386. doi:10.1038/s41392-023-01619-w.
   PubMed Web of Science ®Google Scholar
• He Y, Fu L, Li Y, Wang W, Gong M, Zhang J, Dong X, Huang J, Wang Q, Mackay CR. et al. Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8+ T cell immunity. Cell Metab. 2021;33(5):988–1000.e7. doi:10.1016/j.cmet.2021.03.002.
   PubMed Web of Science ®Google Scholar
• Walter J, Armet AM, Finlay BB, Shanahan F. Establishing or exaggerating causality for the gut microbiome: lessons from human microbiota-associated rodents. Cell. 2020;180(2):221–232. doi:10.1016/j.cell.2019.12.025.
   PubMed Web of Science ®Google Scholar
• Danese S. IBD: of mice and men—shedding new light on IL-13 activity in IBD. Nat Rev Gastroenterol Hepatol. 2011;8(3):128–129. doi:10.1038/nrgastro.2011.17.
   PubMed Web of Science ®Google Scholar
• Winogrodzki T, Metwaly A, Grodziecki A, Liang W, Klinger B, Flisikowska T, Fischer K, Flisikowski K, Steiger K, Haller D. et al. TNF ΔARE pigs: a translational Crohn’s disease model. J Crohns Colitis. 2023;17(7):1128–1138. doi:10.1093/ecco-jcc/jjad034.
   PubMed Web of Science ®Google Scholar
• Keubler LM, Buettner M, Häger C, Bleich A. A multihit model: colitis lessons from the interleukin-10-deficient mouse. Inflamm Bowel Dis. 2015;21(8):1967–1975. doi:10.1097/MIB.0000000000000468.
   PubMed Web of Science ®Google Scholar
• Hu Y, Chen F, Ye H, Lu B. Integrative analysis of the gut microbiome and metabolome in a rat model with stress induced irritable bowel syndrome. Sci Rep. 2021;11(1):17596–17606. doi:10.1038/s41598-021-97083-z.
   PubMed Web of Science ®Google Scholar
• Roy U, Gálvez EJC, Iljazovic A, Lesker TR, Błażejewski AJ, Pils MC, Heise U, Huber S, Flavell RA, Strowig T. Distinct microbial communities trigger colitis development upon intestinal barrier damage via innate or adaptive immune cells. Cell Rep. 2017;21(4):994–1008. doi:10.1016/j.celrep.2017.09.097.
   PubMed Web of Science ®Google Scholar
• Garrett WS, Gallini CA, Yatsunenko T, Michaud M, DuBois A, Delaney ML, Punit S, Karlsson M, Bry L, Glickman JN. et al. Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe. 2010;8(3):292–300. doi:10.1016/j.chom.2010.08.004.
   PubMed Web of Science ®Google Scholar
• Atarashi K, Tanoue T, Oshima K, Suda W, Nagano Y, Nishikawa H, Fukuda S, Saito T, Narushima S, Hase K. et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature. 2013;500(7461):232–236. doi:10.1038/nature12331.
   PubMed Web of Science ®Google Scholar
• Pascual-García A, Bonhoeffer S, Bell T. Metabolically cohesive microbial consortia and ecosystem functioning. Philos Trans R Soc Lond B Biol Sci. 2020;375(1798):20190245. doi:10.1098/rstb.2019.0245.
   PubMed Web of Science ®Google Scholar
• Du Z, Hudcovic T, Mrazek J, Kozakova H, Srutkova D, Schwarzer M, Tlaskalova-Hogenova H, Kostovcik M, Kverka M. Development of gut inflammation in mice colonized with mucosa-associated bacteria from patients with ulcerative colitis. Gut Pathog. 2015;7(1):32–45. doi:10.1186/s13099-015-0080-2.
   PubMedGoogle Scholar
• Gilbert JA, Blaser MJ, Caporaso JG, Jansson JK, Lynch SV, Knight R. Current understanding of the human microbiome. Nat Med. 2018;24(4):392–400. doi:10.1038/nm.4517.
   PubMed Web of Science ®Google Scholar
• Li J, Jia H, Cai X, Zhong H, Feng Q, Sunagawa S, Arumugam M, Kultima JR, Prifti E, Nielsen T. et al. An integrated catalog of reference genes in the human gut microbiome. Nat Biotechnol. 2014;32(8):834–841. doi:10.1038/nbt.2942.
   PubMed Web of Science ®Google Scholar
• Zeevi D, Korem T, Godneva A, Bar N, Kurilshikov A, Lotan-Pompan M, Weinberger A, Fu J, Wijmenga C, Zhernakova A. et al. Structural variation in the gut microbiome associates with host health. Nature. 2019;568(7750):43–48. doi:10.1038/s41586-019-1065-y.
   PubMed Web of Science ®Google Scholar
• Markets and Markets. Microfluidics market by materials (polymers, silicon, glass), pharmaceuticals (microreactors, toxicity screening, lab on chip, proteomic & genomic analysis) drug delivery devices (microneedles, micropumps), IVD (POC) – global trends & forecast to 2018. 2013.
   Google Scholar
• Moossavi S, Arrieta MC, Sanati-Nezhad A, Bishehsari F. Gut-on-chip for ecological and causal human gut microbiome research. Trends Microbiol. 2022;30(8):710–721. doi:10.1016/j.tim.2022.01.014.
   PubMed Web of Science ®Google Scholar
• Leung CM, de Haan P, Ronaldson-Bouchard K, Kim GE, Ko J, Rho HS, Chen Z, Habibovic P, Jeon NL, Takayama S. et al. A guide to the organ-on-a-chip. Nat Rev Methods Primers. 2022;2(1):33–61. doi:10.1038/s43586-022-00118-6.
   Google Scholar
• Low LA, Mummery C, Berridge BR, Austin CP, Tagle DA. Organs-on-chips: into the next decade. Nat Rev Drug Discov. 2021;20(5):345–361. doi:10.1038/s41573-020-0079-3.
   PubMed Web of Science ®Google Scholar
• Sin A, Chin KC, Jamil MF, Kostov Y, Rao G, Shuler ML. The design and fabrication of three-chamber microscale cell culture analog devices with integrated dissolved oxygen sensors. Biotechnol Prog. 2004;20(1):338–345. doi:10.1021/bp034077d.
   PubMed Web of Science ®Google Scholar
• Huh D, Matthews BD, Mammoto A, Montoya-Zavala M, Hsin HY, Ingber DE. Reconstituting organ-level lung functions on a chip. Science. 2010;328(5986):1662–1668. doi:10.1126/science.1188302.
   PubMed Web of Science ®Google Scholar
• Signore MA, De Pascali C, Giampetruzzi L, Siciliano PA, Francioso L. Gut-on-chip microphysiological systems: latest advances in the integration of sensing strategies and adoption of mature detection mechanisms. Sens Bio-Sens Res. 2021;33:100443. doi:10.1016/j.sbsr.2021.100443.
   Google Scholar
• Ingber DE. Human organs-on-chips for disease modelling, drug development and personalized medicine. Nat Rev Genet. 2022;23(8):467–491. doi:10.1038/s41576-022-00466-9.
   PubMed Web of Science ®Google Scholar
• Kopec AK, Yokokawa R, Khan N, Horii I, Finley JE, Bono CP, Donovan C, Roy J, Harney J, Burdick AD. et al. Microphysiological systems in early stage drug development: perspectives on current applications and future impact. J Toxicol Sci. 2021;46(3):99–114. doi:10.2131/jts.46.99.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Huang S, Zhong W, Chen W, Yao B, Wang X. 3D organoids derived from the small intestine: an emerging tool for drug transport research. Acta Pharm Sin B. 2021;11(7):1697–1707. doi:10.1016/j.apsb.2020.12.002.
   PubMed Web of Science ®Google Scholar
• Zhang B, Radisic M. Organ-on-a-chip devices advance to market. Lab Chip. 2017;17(14):2395–2420. doi:10.1039/c6lc01554a.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Ingber DE. Gut-on-a-Chip microenvironment induces human intestinal cells to undergo villus differentiation. Integr Biol (Camb). 2013;5(9):1130–1140. doi:10.1039/c3ib40126j.
   PubMed Web of Science ®Google Scholar
• Kim J, Koo BK, Knoblich JA. Human organoids: model systems for human biology and medicine. Nat Rev Mol Cell Biol. 2020;21(10):571–584. doi:10.1038/s41580-020-0259-3.
   PubMed Web of Science ®Google Scholar
• Shah P, Fritz JV, Glaab E, Desai MS, Greenhalgh K, Frachet A, Niegowska M, Estes M, Jäger C, Seguin-Devaux C. et al. A microfluidics-based in vitro model of the gastrointestinal human–microbe interface. Nat Commun. 2016;7(1):11535. doi:10.1038/ncomms11535.
   PubMedGoogle Scholar
• Lucchetti M, Werr G, Johansson S, Barbe L, Grandmougin L, Wilmes P, Tenje M. Integration of multiple flexible electrodes for real-time detection of barrier formation with spatial resolution in a gut-on-chip system. Microsyst Nanoeng. 2024;10(1):18. doi:10.1038/s41378-023-00640-x.
   PubMed Web of Science ®Google Scholar
• Nazari H, Shrestha J, Naei VY, Bazaz SR, Sabbagh M, Thiery JP, Warkiani ME. Advances in TEER measurements of biological barriers in microphysiological systems. Biosens Bioelectron. 2023;234:115355. doi:10.1016/j.bios.2023.115355.
   PubMed Web of Science ®Google Scholar
• Workman MJ, Gleeson JP, Troisi EJ, Estrada HQ, Kerns SJ, Hinojosa CD, Hamilton GA, Targan SR, Svendsen CN, Barrett RJ. Enhanced utilization of induced pluripotent stem cell–derived human intestinal organoids using microengineered chips. Cell Mol Gastroenterol Hepatol. 2017;5(4):669–677.e2. doi:10.1016/j.jcmgh.2017.12.008.
   PubMed Web of Science ®Google Scholar
• Ternes D, Tsenkova M, Pozdeev VI, Meyers M, Koncina E, Atatri S, Schmitz M, Karta J, Schmoetten M, Heinken A. et al. The gut microbial metabolite formate exacerbates colorectal cancer progression. Nat Metab. 2022;4(4):458–475. doi:10.1038/s42255-022-00558-0.
   PubMedGoogle Scholar
• Beaurivage C, Kanapeckaite A, Loomans C, Erdmann KS, Stallen J, Janssen RAJ. Development of a human primary gut-on-a-chip to model inflammatory processes. Sci Rep. 2020;10(1):21475. doi:10.1038/s41598-020-78359-2.
   PubMed Web of Science ®Google Scholar
• Maurer M, Gresnigt MS, Last A, Wollny T, Berlinghof F, Pospich R, Cseresnyes Z, Medyukhina A, Graf K, Gröger M. et al. A three-dimensional immunocompetent intestine-on-chip model as in vitro platform for functional and microbial interaction studies. Biomaterials. 2019;220:119396. doi:10.1016/j.biomaterials.2019.119396.
   PubMed Web of Science ®Google Scholar
• Gabriel-Segard T, Rontard J, Miny L, Dubuisson L, Batut A, Debis D, Gleyzes M, François F, Larramendy F, Soriano A. et al. Proof-of-concept human organ-on-chip study: first step of platform to assess neuro-immunological communication involved in inflammatory bowel diseases. Int J Mol Sci. 2023;24(13):10568. doi:10.3390/ijms241310568.
   PubMed Web of Science ®Google Scholar
• Zhang J, Huang YJ, Yoon JY, Kemmitt J, Wright C, Schneider K, Sphabmixay P, Hernandez-Gordillo V, Holcomb SJ, Bhushan B. et al. Primary human colonic mucosal barrier crosstalk with super oxygen-sensitive Faecalibacterium prausnitzii in continuous culture. Med. 2021;2(1):74–98.e9. doi:10.1016/j.medj.2020.07.001.
   PubMedGoogle Scholar
• Darfeuille-Michaud A, Boudeau J, Bulois P, Neut C, Glasser AL, Barnich N, Bringer MA, Swidsinski A, Beaugerie L, Colombel JF. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease. Gastroenterology. 2004;127(2):412–421. doi:10.1053/j.gastro.2004.04.061.
   PubMed Web of Science ®Google Scholar
• Shin W, Kim HJ. Intestinal barrier dysfunction orchestrates the onset of inflammatory host–microbiome cross-talk in a human gut inflammation-on-a-chip. Proc Natl Acad Sci U S A. 2018;115(45):E10539–E10547. doi:10.1073/pnas.1810819115.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Li H, Collins JJ, Ingber DE. Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip. Proc Natl Acad Sci U S A. 2016 Jan 5;113(1):E7–15. doi:10.1073/pnas.1522193112.
   PubMed Web of Science ®Google Scholar
• Jalili-Firoozinezhad S, Gazzaniga FS, Calamari EL, Camacho DM, Fadel CW, Bein A, Swenor B, Nestor B, Cronce MJ, Tovaglieri A. et al. A complex human gut microbiome cultured in an anaerobic intestine-on-a-chip. Nat Biomed Eng. 2019;3(7):520–531. doi:10.1038/s41551-019-0397-0.
   PubMed Web of Science ®Google Scholar
• Marzorati M, Vanhoecke B, De Ryck T, Sadaghian Sadabad M, Pinheiro I, Possemiers S, Van den Abbeele P, Derycke L, Bracke M, Pieters J. et al. The HMI™ module: a new tool to study the host-microbiota interaction in the human gastrointestinal tract in vitro. BMC Microbiol. 2014;14(1):133–146. doi:10.1186/1471-2180-14-133.
   PubMedGoogle Scholar
• Kim HJ, Huh D, Hamilton G, Ingber DE. Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow. Lab Chip. 2012;12(12):2165–2174. doi:10.1039/c2lc40074j.
   PubMed Web of Science ®Google Scholar
• Lagier JC, Armougom F, Million M, Hugon P, Pagnier I, Robert C, Bittar F, Fournous G, Gimenez G, Maraninchi M. et al. Microbial culturomics: paradigm shift in the human gut microbiome study. Clin Microbiol Infect. 2012;18(12):1185–1193. doi:10.1111/1469-0691.12023.
   PubMed Web of Science ®Google Scholar
• Lagier JC, Dubourg G, Million M, Cadoret F, Bilen M, Fenollar F, Levasseur A, Rolain JM, Fournier PE, Raoult D. Culturing the human microbiota and culturomics. Nat Rev Microbiol. 2018;16(9):540–550. doi:10.1038/s41579-018-0041-0.
   PubMed Web of Science ®Google Scholar